Get the Stockscreener App
2.13
0.00%
0.00
After Hours:
2.13
Ac Immune Sa stock is traded at $2.13, with a volume of 70,818.
It is up +0.00% in the last 24 hours and up +3.90% over the past month.
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
See More
Previous Close:
$2.13
Open:
$2.13
24h Volume:
70,818
Relative Volume:
0.54
Market Cap:
$213.87M
Revenue:
-
Net Income/Loss:
$-60.14M
P/E Ratio:
-3.0021
EPS:
-0.7095
Net Cash Flow:
$-68.17M
1W Performance:
-0.47%
1M Performance:
+3.90%
6M Performance:
-22.26%
1Y Performance:
-37.17%
1-Day Range:
$2.09
$2.19
1-Week Range:
$2.04
$2.25
52-Week Range:
$1.4299
$3.98
Ac Immune Sa Stock (ACIU) Company Profile
Compare ACIU with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ACIU
Ac Immune Sa
|
2.13 | 214.28M | 0 | -60.14M | -68.17M | -0.7095 |
|
VRTX
Vertex Pharmaceuticals Inc
|
392.79 | 100.07B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.41 | 59.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
448.91 | 58.03B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
653.83 | 39.93B | 3.06B | 1.28B | -614.78M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
321.36 | 36.82B | 3.81B | -644.79M | -669.77M | -6.24 |
Ac Immune Sa Stock (ACIU) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-31-24 | Initiated | BTIG Research | Buy |
| Feb-01-19 | Downgrade | UBS | Buy → Neutral |
| Jan-04-19 | Initiated | UBS | Buy |
| Apr-05-18 | Initiated | H.C. Wainwright | Buy |
| Mar-23-18 | Downgrade | Credit Suisse | Outperform → Neutral |
| Oct-18-16 | Initiated | Credit Suisse | Outperform |
| Oct-18-16 | Initiated | Jefferies | Buy |
| Oct-18-16 | Initiated | Leerink Partners | Outperform |
View All
Ac Immune Sa Stock (ACIU) Latest News
Using AI based signals to follow AC Immune SATrade Ideas & Low Risk Investment Opportunities - Newser
Identifying reversal signals in AC Immune SAShare Buyback & Accurate Entry and Exit Point Alerts - Newser
Chart based exit strategy for AC Immune SAJuly 2025 Price Swings & Accurate Trade Setup Notifications - Newser
Visual analytics tools that track AC Immune SA performanceQuarterly Market Summary & AI Forecast for Swing Trade Picks - Newser
AC Immune SA Included in Top Momentum ScanQuarterly Market Summary & High Yield Equity Trading Tips - thegnnews.com
What momentum shifts mean for AC Immune SATrade Signal Summary & AI Forecasted Entry/Exit Points - Newser
Why AC Immune SA stock attracts strong analyst attention2025 Retail Activity & Safe Entry Zone Identification - Newser
Using data models to predict AC Immune SA stock movementJuly 2025 Analyst Calls & Low Risk High Reward Ideas - Newser
When is the best time to exit AC Immune SA2025 Analyst Calls & Precise Buy Zone Tips - Newser
Advanced analytics toolkit walkthrough for AC Immune SAInflation Watch & Safe Entry Point Identification - Newser
Published on: 2025-08-15 16:03:45 - Newser
How to integrate AC Immune SA into portfolio analysis toolsQuarterly Profit Summary & High Accuracy Swing Trade Signals - Newser
Developing predictive dashboards with AC Immune SA dataOil Prices & Growth Focused Stock Reports - Newser
Ranking AC Immune SA among high performing stocks via toolsFree Verified Signal From Chart Patterns - Newser
Can AC Immune SA disrupt its industryNext 10x Stock Ideas - kangso.co.kr
Backtesting results for AC Immune SA trading strategiesLow Exposure Strategy with Sector Analysis - Newser
Using R and stats models for AC Immune SA forecastingInvestment Timeline and ROI Summary Report - Newser
Is AC Immune SA stock poised for growthAI Swing Strategy Signal Forecasting System - Newser
Analyzing drawdowns of AC Immune SA with statistical toolsSupport and Resistance Zone Summary Chart - Newser
How to use Fibonacci retracement on AC Immune SAHigh Reward Picks with Tight Risk Control - Newser
Is AC Immune SA reversing from oversold territoryFree Capital Preserving Trade Plan Templates - Newser
Can machine learning forecast AC Immune SA recoveryFree High Accuracy Alerts for ROI Traders - Newser
What makes AC Immune SA stock price move sharplyForecasting Stock Moves with AI Insights - Newser
Can AC Immune SA expand its profit marginsSmart Beta Portfolio Candidates - sisaissue.com
AC Immune SA: Promising Pipeline and Strong Financial Position Justify Buy Rating - TipRanks
AC Immune Reports Q2 2025 Financial Progress - The Globe and Mail
Q3 Earnings Forecast for AC Immune Issued By Leerink Partnrs - Defense World
Visualizing AC Immune SA stock with heatmapsFree Weekly Growth Stock Entry Point Alerts - Newser
Will AC Immune SA stock split in the near futureFree Low Risk Swing Trade Opportunity List - Newser
Ac Immune Sa Stock (ACIU) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.41%
0.88%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):